TP53 and neoplasm: Somatic mutations in FGFR3 are more frequent in low-risk NMIT, while mutations in TP53 and RB are mainly involved in high-risk NMIT and MIT [5], [6]; mutations in PIK3CA and HRAS occur similarly in the two tumor subtypes.